Page 102 - Mesenchymal Stem cells, Exosomes and vitamins in the fight aginst COVID

Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19

32. Leibacher J, Henschler R. 42. Armitage J, Tan DBA, Troedson R, et with bone marrow mononuclear cells
Biodistribution, migration and al. Mesenchymal stromal cell infusion delivered through a graft vessel for
homing of systemically applied modulates systemic immunological patients with previous myocardial
mesenchymal stem/stromal cells. responses in stable COPD patients: A infarction and chronic heart failure.
Stem Cell Res Ther 2016; 7:7. phase I pilot study. Eur Respir J 2018; Journal of the American College of
33. Lee RH, Pulin AA, Seo MJ, et al. 51:1702369. Cardiology 2011; 57:2409-2415.
Intravenous hMSCs improve 43. Chambers DC, Enever D, Ilic N, et al. 51. Lu M, Liu S, Zheng Z, et al. A pilot
myocardial infarction in mice because A phase 1b study of placenta-derived trial of autologous bone marrow
cells embolized in lung are activated to mesenchymal stromal cells in patients mononuclear cell transplantation
secrete the anti-inflammatory protein with idiopathic pulmonary fibrosis. through grafting artery: A sub-study
TSG-6. Cell Stem Cell 2009; 5:54-63. Respirology 2014; 19:1013-1018. focused on segmental left ventricular
34. Sanganalmath SK, Bolli R. Cell therapy 44. Averyanov A, Koroleva I, function recovery and scar reduction.
for heart failure: A comprehensive Konoplyannikov M, et al. First-in- International Journal of Cardiology
overview of experimental and clinical human high-cumulative-dose stem 2013; 168:2221-2227.
studies, current challenges, and future cell therapy in idiopathic pulmonary 52. Qi Z, Liu S, Duan F, et al. Effects of
directions. Circ Res 2013; 113:810-834. fibrosis with rapid lung function bone marrow mononuclear cells
35. Jun Hong S, Rogers PI, Kihlken decline. Stem Cells Transl Med 2020; delivered through a graft vessel in
J, et al. Intravenous xenogeneic 9:6-16. patients with previous myocardial
transplantation of human adipose- 45. Liu WW, Yu W, Chen JY, et al. Effects of infarction and chronic heart failure:
derived stem cells improves left human umbilical cord mesenchymal An echocardiographic study of left
ventricular function and microvascular stem cells in the treatment of ventricular dyssynchrony. Journal of
integrity in swine myocardial paraquat-induced lung injury. [Article Clinical Ultrasound 2018; 46:512-518.
infarction model. Catheter Cardiovasc in Chinese]. Chin J Ind Hyg Occup Dis 53. Tuma J, Fernández-Viña R, Carrasco
Interv 2015; 86:E38-E48. 2012; 30:811-815. A, et al. Safety and feasibility of
percutaneous retrograde coronary
36. Zheng G, Huang L, Tong H, et al. 46. Chen S, Zhao K, Lin R, et al. The
Treatment of acute respiratory distress efficacy of mesenchymal stem cells sinus delivery of autologous
syndrome with allogeneic adipose- in bronchiolitis obliterans syndrome bone marrow mononuclear cell
derived mesenchymal stem cells: A after allogeneic HSCT: A multicenter transplantation in patients with
randomized, placebo-controlled pilot prospective cohort study. EBioMedicine chronic refractory angina. J Transl Med
study. Respir Res 2014; 15:39. 2019; 49:213-222. 2011; 9:183.
37. Simonson OE, Mougiakakos D, 47. Lasala GP, Silva JA, Kusnick BA, et al. 54. Lee JW, Lee SH, Youn YJ, et al. A
Heldring N, et al. In vivo effects of Combination stem cell therapy for randomized, open-label, multicenter
mesenchymal stromal cells in two the treatment of medically refractory trial for the safety and efficacy of adult
patients with severe acute respiratory coronary ischemia: A phase I study. mesenchymal stem cells after acute
distress syndrome. Stem Cells Transl Cardiovascular Revascularization myocardial infarction. J Korean Med Sci
Med 2015; 4:1199-213. Medicine 2010; 3:89-96. 2014; 29:23-31.
38. Wilson JG, Liu KD, Zhuo H, et al. 48. Hare JM, Traverse JH, Henry TD, 55. Gao LR, Chen Y, Zhang NK, et al.
Mesenchymal stem (stromal) cells for et al. A randomized, double-blind, Intracoronary infusion of Wharton’s
treatment of ARDS: A phase 1 clinical placebo-controlled, dose-escalation jelly-derived mesenchymal stem
trial. Lancet Respir Med 2015; 3:24-32. study of intravenous adult human cells in acute myocardial infarction:
39. Chen J, Hu C, Chen L, et al. Clinical mesenchymal stem cells (prochymal) Double-blind, randomized controlled
trial. BMC Medicine 2015; 13:162.
study of mesenchymal stem cell after acute myocardial infarction. J Am
treating acute respiratory distress Coll Cardiol 2009; 54:2277-2286. 56. Xue HL, Zeng WZ, Wu XL, et al.
syndrome induced by epidemic 49. Bartolucci J, Verdugo FJ, González Clinical therapeutic effects of human
influenza A (H7N9) infection, a hint PL, et al. Safety and efficacy of the umbilical cord-derived mesenchymal
for COVID-19 treatment. Engineering intravenous infusion of umbilical stem cells transplantation in the
(Beijing) 2020 Feb 28. [Epub ahead of cord mesenchymal stem cells in treatment of end-stage liver disease.
print]. patients with heart failure: A phase Transplant Proc 2015; 47:412-418.
40. Leng Z, Zhu R, Hou W, et al. 1/2 randomized controlled trial 57. Jang YO, Kim YJ, Baik SK, et al.
Transplantation of ACE2- mesenchymal (RIMECARD Trial [Randomized Histological improvement following
stem cells improves the outcome of Clinical Trial of Intravenous Infusion administration of autologous bone
patients with COVID-19 pneumonia. Umbilical Cord Mesenchymal Stem marrow-derived mesenchymal stem
Aging Dis 2020; 11:216-228. Cells on Cardiopathy]). Journal of the cells for alcoholic cirrhosis: A pilot
Medical Association of Thailand 2017; study. Liver Int 2014; 34:33-41.
41. Weiss DJ, Casaburi R, Flannery R, et 121:1192-1204.
al. A placebo-controlled, randomized 58. Suk KT, Yoon JH, Kim MY, et al.
trial of mesenchymal stem cells in 50. Hu S, Liu S, Zheng Z, et al. Isolated Transplantation with autologous bone
COPD. Chest 2013; 143:1590-1598. coronary artery bypass graft combined marrow-derived mesenchymal stem

www.painphysicianjournal.com S419